Increasing Caregiver Engagement in Juvenile Drug Courts

Summary

The purpose of this study is to test a prize-based contingency management intervention for increasing caregiver engagement in juvenile drug court and adolescent drug treatment, and for achieving the ultimate outcomes of reduced substance use and delinquent behavior among drug court-involved youth.

Conditions

• Substance Abuse

Interventions

BEHAVIORAL

Caregiver Contingency Management + Usual Drug Court Treatment

In addition to receiving JDC treatment as usual described below, caregiver participants will receive prize draws for engaging in activities consistent with their adolescents' successful completion of the JDC program during the time the youth is actively involved in JDC and substance abuse treatment. Specific activities that may be reinforced include: attendance at drug court hearings; accompanying the youth to probation meetings; participating in home visits; attendance at the youth's drug treatment sessions; attendance at mental health provider meetings; attending groups for parents of youth with substance abuse issues; and completing other verifiable treatment-related activities. All activities will meet the goals of (directly or indirectly) enhancing caregiver participation in the JDC and/or treatment process. Caregivers will receive escalating chances for tangible reinforcers each week for completing up to 3 of the activities agreed upon by the caregiver and the therapist.

BEHAVIORAL

Usual Drug Court Treatment

Standard outpatient substance abuse treatment services that a young person would receive while participating in JDC.

Sponsors & Collaborators

• National Institute on Minority Health and Health Disparities (NIMHD)

  collaborator NIH

• Wayne State University

  collaborator OTHER

• Alliant International University

  collaborator OTHER

• Baylor University

  collaborator OTHER

• Medical University of South Carolina

  lead OTHER

Principal Investigators

• Phillippe Cunningham, Ph.D. · Medical University of South Carolina

• David Ledgerwood, Ph.D. · Wayne State University

• Stacy Ryan, Ph.D. · The University of Texas Health Science Center at San Antonio

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

13 Years

Max Age

89 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-10-13

Primary Completion

2023-12-12

Completion

2024-12-12

Countries

• United States

Study Locations